Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Carbinoxamine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carbinoxamine maleate and what is the scope of carbinoxamine maleate patent protection?

Carbinoxamine maleate
is the generic ingredient in three branded drugs marketed by Vintage Pharms, Ortho Mcneil Pharm, Cypress Pharm, Invagen Pharms, Mikart, Mcneil, Tris Pharma Inc, Mission Pharmacal Co, and Mikart Inc, and is included in twelve NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has nineteen patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Eight suppliers are listed for this compound.

Summary for Generic Name: carbinoxamine maleate

Tradenames:3
Patents:3
Applicants:9
NDAs:12
Drug Master File Entries: see list7
Suppliers / Packagers: see list8
Bulk Api Vendors: see list20
Clinical Trials: see list70
Patent Applications: see list978
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:carbinoxamine maleate at DailyMed

Pharmacology for Ingredient: carbinoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cypress Pharm
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL090417-001Aug 23, 2010AARXNoNo► Subscribe► Subscribe
Tris Pharma Inc
KARBINAL ER
carbinoxamine maleate
SUSPENSION, EXTENDED RELEASE;ORAL022556-001Mar 28, 2013RXYesYes8,062,667► SubscribeY ► Subscribe
Mikart
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL040442-001Mar 19, 2003AARXNoYes► Subscribe► Subscribe
Mikart
CARBINOXAMINE MALEATE
carbinoxamine maleate
SOLUTION;ORAL040458-001Apr 25, 2003AARXNoYes► Subscribe► Subscribe
Ortho Mcneil Pharm
CLISTIN
carbinoxamine maleate
TABLET;ORAL008915-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot